Concepedia

Jay Visaria

JV

Statistics

Publications

8

Citations

268

H-Index

8

Active since

2008

Affiliations

Wilmington University(Current)

Novo Nordisk (United States)

Express Scripts Holding Company (United States)

Janssen (United States)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Jay Visaria is an author at Wilmington University specializing in diabetes, health insurance, and health policy.

Top concepts

Publications per year

2008–2021

8

Publications

8

Incentives for orphan drug research and development in the United States

Enrique Seoane‐Vazquez, Rosa Rodríguez-Monguió, Sheryl L. Szeinbach et al. · Orphanet Journal of Rare Diseases · 2008 · 134 citations · Full text

<p>Healthcare Costs of Diabetes and Microvascular and Macrovascular Disease in Individuals with Incident Type 2 Diabetes Mellitus: A Ten-Year Longitudinal Study</p>

Jay Visaria, Neeraj N. Iyer, Amit D. Raval et al. · ClinicoEconomics and Outcomes Research · 2020 · 24 citations · Full text

Incidence and Prevalence of Microvascular and Macrovascular Diseases and All-cause Mortality in Type 2 Diabetes Mellitus: A 10-year Study in a US Commercially Insured and Medicare Advantage Population

Jay Visaria, Neeraj N. Iyer, Amit D. Raval et al. · Clinical Therapeutics · 2019 · 22 citations

, , +10

Dispensing channel and medication adherence: evidence across 3 therapy classes.

Reethi Iyengar, Rochelle Henderson, Jay Visaria et al. · PubMed · 2013 · 21 citations

Real-World Effectiveness of Once-Weekly Semaglutide From a US Commercially Insured and Medicare Advantage Population

Jay Visaria, Chioma Uzoigwe, Caroline Swift et al. · Clinical Therapeutics · 2021 · 21 citations

1–5 of 8